Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

David Moreno to Humans

This is a "connection" page, showing publications David Moreno has written about Humans.

 
Connection Strength
  
 
 
0.229
  
  1. Moreno DF, Oriol A, de la Rubia J, Hern?ndez MT, I?igo MB, Palomera L, de Arriba F, Gonz?lez Y, Teruel AI, Pardo JL, L?pez de la Gu?a A, Sampol A, R?os-Tamayo R, Sureda A, Guti?rrez NC, Calasanz MJ, Ramos MLM, Mateos MV, San Miguel J, Lahuerta JJ, Blad? J, Rosi?ol L. Is t(11;14) Always a Standard-Risk Cytogenetic Abnormality? Results From GEM05MENOS65 and GEM2012 PETHEMA/GEM Transplantation Trials. Clin Lymphoma Myeloma Leuk. 2025 Jul; 25(7):494-504.
    View in: PubMed
    Score: 0.024
  2. Moreno DF, Fern?ndez de Larrea C. Clinical Implications of Genomic Profile in Waldenstr?m Macroglobulinemia. Hematol Oncol Clin North Am. 2023 08; 37(4):659-670.
    View in: PubMed
    Score: 0.022
  3. Moreno DF, L?pez-Guerra M, Paz S, Oliver-Cald?s A, Mena MP, Correa JG, Battram AM, Osuna M, Rivas-Delgado A, Rodr?guez-Lobato LG, Card?s O, Tovar N, Cibeira MT, Jim?nez-Segura R, Blad? J, Rosi?ol L, Colomer D, Fern?ndez de Larrea C. Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenstr?m macroglobulinaemia. Br J Haematol. 2023 01; 200(2):187-196.
    View in: PubMed
    Score: 0.021
  4. Moreno DF, de Larrea CF, Castillo JJ. New treatment strategies for Waldenstr?m macroglobulinemia. Clin Adv Hematol Oncol. 2022 Aug; 20(8):506-515.
    View in: PubMed
    Score: 0.021
  5. Torner F, Nu?ez JH, Inarejos Clemente EJ, Garraus M, Su?ol M, Mart?nez AD, Moreno D. Total calcaneal allograft reconstruction of an Ewing's sarcoma in a child: Outcome and review of the literature. Cancer Rep (Hoboken). 2022 09; 5(9):e1626.
    View in: PubMed
    Score: 0.020
  6. Moreno DF, Clap?s V, Soler JA, Gonz?lez-Montes Y, Gironella M, Motll? C, Granell M, Abella E, Garc?a-Pintos M, Garc?a-Gui??n A, Cabezudo E, Blad? J, Rosi?ol L. Real-World Evidence of Daratumumab Monotherapy in Relapsed/Refractory Multiple Myeloma Patients and Efficacy on Soft-Tissue Plasmacytomas. Clin Lymphoma Myeloma Leuk. 2022 08; 22(8):635-642.
    View in: PubMed
    Score: 0.020
  7. Moreno DF, Cid J. Graft-versus-host disease. Med Clin (Barc). 2019 01 04; 152(1):22-28.
    View in: PubMed
    Score: 0.016
  8. Rodr?guez-Lobato LG, de Daniel A, Pereira A, Fern?ndez de Larrea C, Tovar N, Cibeira MT, Moreno DF, Mateos JM, Llobet N, Carcelero E, Mun?rriz D, Blad? J, Rosi?ol L. Attrition rates and treatment outcomes in multiple myeloma: real-world data over a 40-year period. Blood Cancer J. 2025 May 26; 15(1):103.
    View in: PubMed
    Score: 0.006
  9. Zugasti I, Tormo-Ratera M, Oliver-Cald?s A, Soler-Perromat JC, Gonz?lez-Calle V, Moreno DF, Caba?as V, L?pez-Mu?oz N, Bartolom?-Solanas ?, Espa?ol-Rego M, Reguera-Ortega JL, Rosi?ol L, L?pez-Corral L, Tovar N, Rodr?guez-Lobato LG, Alvarez Perez RM, Varea S, Olesti E, Gomez-Grande A, Frutos L, Tamayo P, Juan M, Moraleda JM, Urbano-Ispizua ?, Gonz?lez-Navarro EA, Mart?nez-L?pez J, Mateos MV, Tom?s X, Setoain X, Fern?ndez de Larrea C. Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myeloma. Blood Adv. 2025 Feb 11; 9(3):571-582.
    View in: PubMed
    Score: 0.006
  10. Battram AM, Ma??-Pujol J, Moreno DF, Oliver-Cald?s A, Carpio J, Cardus O, Rodr?guez-Lobato LG, Urbano-Ispizua ?, Fern?ndez de Larrea C. Genetic disruption of Blimp-1 drastically augments the antitumor efficacy of BCMA-targeting CAR T cells. Blood Adv. 2025 Feb 11; 9(3):627-641.
    View in: PubMed
    Score: 0.006
  11. Lozano E, Mena MP, Garrabou G, Card?s O, D?az T, Moreno DF, Ma??-Pujol J, Oliver-Cald?s A, Battram A, Tovar N, Cibeira MT, Rodr?guez-Lobato LG, Blad? J, Fern?ndez de Larrea C, Rosi?ol L. Increased PVR Expression on Bone Marrow Macrophages May Promote Resistance to TIGIT Blockade in Multiple Myeloma. Clin Cancer Res. 2024 Sep 03; 30(17):3944-3955.
    View in: PubMed
    Score: 0.006
  12. Oliver-Caldes A, Espa?ol-Rego M, Zabaleta A, Gonz?lez-Calle V, Navarro-Vel?zquez S, Inog?s S, de Cerio AL, Caba?as V, L?pez-Mu?oz N, Rodr?guez-Otero P, Reguera JL, Moreno DF, Mart?nez-Cibrian N, L?pez-Corral L, P?rez-Amill L, Martin-Antonio B, Rosi?ol L, Cid J, Tovar N, S?ez-Pe?ataro J, L?pez-Parra M, Olesti E, Guill?n E, Varea S, Rodr?guez-Lobato LG, Battram AM, Gonz?lez MS, S?nchez-Salinas A, Gonz?lez-Navarro A, Ortiz-Maldonado V, Delgado J, Pr?sper F, Juan M, Mart?nez-L?pez J, Moraleda JM, Mateos MV, Urbano-Ispizua ?, Paiva B, Pascal M, Fern?ndez de Larrea C. Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma. Clin Cancer Res. 2024 May 15; 30(10):2085-2096.
    View in: PubMed
    Score: 0.006
  13. Pijuan J, Moreno DF, Yahya G, Moisa M, Ul Haq I, Krukiewicz K, Mosbah R, Metwally K, Cavalu S. Regulatory and pathogenic mechanisms in response to iron deficiency and excess in fungi. Microb Biotechnol. 2023 11; 16(11):2053-2071.
    View in: PubMed
    Score: 0.006
  14. Jim?nez-Segura R, Rosi?ol L, Cibeira MT, Fern?ndez de Larrea C, Tovar N, Rodr?guez-Lobato LG, Blad? E, Moreno DF, Oliver-Cald?s A, Blad? J. Paraskeletal and extramedullary plasmacytomas in multiple myeloma at diagnosis and at first relapse: 50-years of experience from an academic institution. Blood Cancer J. 2022 09 16; 12(9):135.
    View in: PubMed
    Score: 0.005
  15. Oliver-Caldes A, Jim?nez R, Espa?ol-Rego M, Cibeira MT, Ortiz-Maldonado V, Quintana LF, Castillo P, Guijarro F, Tovar N, Montoro M, Benitez-Ribas D, Bataller A, Gonz?lez-Navarro EA, Cid J, Lozano M, Perez-Amill L, Martin-Antonio B, Mena MP, Moreno DF, Rodr?guez-Lobato LG, Campistol JM, Calvo G, Blad? J, Rosi?ol L, Juan M, Pascal M, Urbano-Ispizua A, Fern?ndez de Larrea C. First report of CART treatment in AL amyloidosis and relapsed/refractory multiple myeloma. J Immunother Cancer. 2021 12; 9(12).
    View in: PubMed
    Score: 0.005
  16. Isola I, Bras?-Maristany F, Moreno DF, Mena MP, Oliver-Calders A, Par? L, Rodr?guez-Lobato LG, Martin-Antonio B, Cibeira MT, Blad? J, Rosi?ol L, Prat A, Lozano E, Fern?ndez de Larrea C. Gene Expression Analysis of the Bone Marrow Microenvironment Reveals Distinct Immunotypes in Smoldering Multiple Myeloma Associated to Progression to Symptomatic Disease. Front Immunol. 2021; 12:792609.
    View in: PubMed
    Score: 0.005
  17. Rodr?guez-Lobato LG, Pereira A, Fern?ndez de Larrea C, Cibeira MT, Tovar N, Jim?nez-Segura R, Moreno DF, Oliver-Cald?s A, Rosi?ol L, Blad? J. Real-world data on survival improvement in patients with multiple myeloma treated at a single institution over a 45-year period. Br J Haematol. 2022 02; 196(3):649-659.
    View in: PubMed
    Score: 0.005
  18. Isola I, Moreno DF, Moga E, Mena MP, Tovar N, Rodr?guez-Lobato LG, Oliver-Cald?s A, Salgado MC, Bras?-Maristany F, Yag?e J, Cibeira MT, Prat A, Rosi?ol L, Blad? J, Fern?ndez de Larrea C. Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced disease. Ann Hematol. 2021 Dec; 100(12):2997-3005.
    View in: PubMed
    Score: 0.005
  19. Yahya G, P?rez AP, Mendoza MB, Parisi E, Moreno DF, Art?s MH, Gallego C, Aldea M. Stress granules display bistable dynamics modulated by Cdk. J Cell Biol. 2021 03 01; 220(3).
    View in: PubMed
    Score: 0.005
  20. Luo X, Song R, Moreno DF, Ryu HY, Hochstrasser M, Acar M. Epigenetic Mechanisms Contribute to Evolutionary Adaptation of Gene Network Activity under Environmental Selection. Cell Rep. 2020 10 27; 33(4):108306.
    View in: PubMed
    Score: 0.005
  21. Rodr?guez-Lobato LG, Mart?nez-Roca A, Moreno DF, Guti?rrez-Garc?a G, Su?rez-Lled? M, Rovira M, Mart?nez C, Rosi?ol L, Almeida Jorge AS, Pedraza A, Cardozo C, Puerta-Alcalde P, Garcia-Vidal C, Mar?n P, Cid J, Lozano M, Gallego C, Hernando A, Segura S, Urbano-Ispizua ?, Fern?ndez-Avil?s F. Impact of intensifying primary antibiotic prophylaxis in at-home autologous stem cell transplantation program for lymphoma patients. Leuk Lymphoma. 2020 07; 61(7):1565-1574.
    View in: PubMed
    Score: 0.004
  22. Castillo JJ, Moreno DF, Arbelaez MI, Hunter ZR, Treon SP. CXCR4 mutations affect presentation and outcomes in patients with Waldenstr?m macroglobulinemia: A systematic review. Expert Rev Hematol. 2019 10; 12(10):873-881.
    View in: PubMed
    Score: 0.004
  23. Cid J, Carbass? G, Su?rez-Lled? M, Moreno DF, Mart?nez C, Guti?rrez-Garc?a G, Fern?ndez-Avil?s F, Rosi?ol L, Giavedoni P, Mascar? JM, Agust? C, Mar?n P, Rovira M, Urbano-Ispizua ?, Lozano M. Efficacy and safety of one-day offline extracorporeal photopheresis schedule processing one total blood volume for treating patients with graft-versus-host disease. Transfusion. 2019 08; 59(8):2636-2642.
    View in: PubMed
    Score: 0.004
  24. Tagarro A, Otheo E, Baquero-Artigao F, Navarro ML, Velasco R, Ruiz M, Pen?n M, Moreno D, Rojo P, Madero R. Dexamethasone for Parapneumonic Pleural Effusion: A Randomized, Double-Blind, Clinical Trial. J Pediatr. 2017 06; 185:117-123.e6.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)